# STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial

> **NCT00367757** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 107 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Ablate AF triggers via PVI
- **PROCEDURE:** Substrate via CFAEs
- **PROCEDURE:** Combined approach for AF ablation

## Key facts

- **NCT ID:** NCT00367757
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367757, "STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00367757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*